Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway (Q47601521)

4 February 2018

title

Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway (English)

1 reference

4 February 2018

author name string

Yan Wang

1

1 reference

4 February 2018

Ingo H Engels

2

1 reference

4 February 2018

Deborah A Knee

3

1 reference

4 February 2018

Marc Nasoff

4

1 reference

4 February 2018

Quinn L Deveraux

5

1 reference

4 February 2018

Kim C Quon

6

1 reference

4 February 2018

publication date

1 May 2004

1 reference

4 February 2018

published in

Cancer Cell

1 reference

4 February 2018

volume

5

1 reference

4 February 2018

issue

5

1 reference

4 February 2018

page(s)

501-512

1 reference

4 February 2018

Targeting death and decoy receptors of the tumour-necrosis factor superfamily

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Repression of c-Myc responsive genes in cycling cells causes G1 arrest through reduction of cyclin E/CDK2 kinase activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

A unified model for apical caspase activation

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Disruption of p53 in human cancer cells alters the responses to therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Purification and use of recombinant inhibitor of apoptosis proteins as caspase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Perspectives on the development of a molecularly targeted agent

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Induction of apoptosis in fibroblasts by c-myc protein

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

A novel mitochondriotoxic small molecule that selectively inhibits tumor cell growth.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Cancer revoked: oncogenes as therapeutic targets

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Genomic targets of the human c-Myc protein

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

The Myc/Max/Mad network and the transcriptional control of cell behavior

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

A matter of life and death

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Creation of human tumour cells with defined genetic elements

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Enumeration of the simian virus 40 early region elements necessary for human cell transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Integrating genetic approaches into the discovery of anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Genomically complex lymphomas undergo sustained tumor regression upon MYC inactivation unless they acquire novel chromosomal translocations

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

c-Myc augments the apoptotic activity of cytosolic death receptor signaling proteins by engaging the mitochondrial apoptotic pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Tumor-cell resistance to death receptor--induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

TRAIL-induced apoptosis and gene induction in HaCaT keratinocytes: differential contribution of TRAIL receptors 1 and 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Role of genetic and epigenetic changes in Burkitt lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Burkitt's lymphoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

MYC oncogenes and human neoplastic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

The myc oncogene: MarvelouslY Complex

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Cell surface Death Receptor signaling in normal and cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

c-MYC: more than just a matter of life and death

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

The TRAIL DISCussion: It is FADD and caspase-8!

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Using cancer genetics to guide the selection of anticancer drug targets

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

New paradigms for cancer drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Two CD95 (APO-1/Fas) signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Nature's TRAIL--on a path to cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Use of isogenic human cancer cells for high-throughput screening and drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

The N-myc paradox: N-myc overexpression in neuroblastomas is associated with sensitivity as well as resistance to apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Promoter structure and transcription initiation sites of the human death receptor 5/TRAIL-R2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

Role of BAX in the apoptotic response to anticancer agents

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900113-8

7 January 2021

10.1016/S1535-6108(04)00113-8

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

15144957

1 reference

4 February 2018